Brighton Park Capital
No summary available yet.
Brighton Park is the definition of a steady, under-the-radar growth equity fund that does exactly what it says on the tin. They're not trying to be the next hot brand name - they just write checks to profitable B2B companies that need growth capital. The healthcare focus is real and deep, which can be incredibly valuable if that's your space. Don't expect them to help you pivot or figure out product-market fit - they invest in businesses that already have their shit together and just need fuel. The partners are competent operators but won't blow you away with visionary insights. Good for founders who want capital plus solid, if unremarkable, board members.
- —Best for: Profitable B2B/healthcare companies needing growth capital, not strategy
- —Known for: Low-key, operationally-focused approach with deep healthcare expertise
- —Watch out for: Limited brand value and network effects compared to marquee funds
Brighton Park Capital focuses on growth equity investments in middle-market B2B software, healthcare technology, and financial services companies. They target businesses with proven revenue models that need capital to scale operations and accelerate growth.
Late-stage growth equity (Series B/C and beyond) in B2B SaaS, healthcare tech, and fintech. Typical check sizes $10-50M for companies doing $10M+ ARR looking to scale rapidly.
Former McKinsey consultant and healthcare executive. Founded Brighton Park after stints at various healthcare companies. Known for deep healthcare domain expertise and operational focus.
Previously at Goldman Sachs and various growth equity funds. Focuses on financial services and B2B software investments. Has a reputation for being very hands-on with portfolio companies.
Former consultant turned investor with experience at several mid-market funds. Known for his work in healthcare IT and services sectors.
Have a specific question about Brighton Park Capital?
Ask Bernie →